Colombia vs Myanmar: Antiretroviral therapy coverage for PMTCT
Colombia
53.0%
in 2023
Myanmar
54.0%
in 2024
Colombia rank
66th
Myanmar rank
65th
Antiretroviral therapy coverage for PMTCT over time
- Colombia
- Myanmar
How they compare
Myanmar currently reports 54.0% against 53.0% in Colombia, a difference of 1.0%.
The two have swapped places 8 times across 24 shared years of data; in 2000 it was Myanmar ahead.
Colombia ranks 66th and Myanmar ranks 65th of 84 countries.
Across the 3 decades both report, Colombia averaged higher in 1 and Myanmar in 2.
Head to head by decade
| Decade | Colombia | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.5% | 13.8% | 0.3% | Myanmar |
| 2010s | 58.2% | 69.7% | 11.5% | Myanmar |
| 2020s | 55.2% | 51.2% | 4.0% | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Colombia or Myanmar?
- Myanmar, at 54.0% against 53.0% in Colombia as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Colombia and Myanmar?
- 1.0%, with Myanmar ahead.
- How many years of comparable data are there for Colombia and Myanmar?
- 24 years are reported by both, from 2000 to 2023.
- How do Colombia and Myanmar rank globally for antiretroviral therapy coverage for pmtct?
- Colombia ranks 66th and Myanmar ranks 65th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).